Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes During Cesarean Section

Recruiting now · Not applicable

Conditions studied: Virtual Reality, Dexmedetomidine, Maternal Anxiety, Stress, Hemodynamics, Neonatal Outcomes, Cesarean Section

In brief

This study aims to compare the efficacy of intravenous dexmedetomidine infusion versus virtual reality (VR) in reducing maternal anxiety, stress, and hemodynamic instability during cesarean section and their effects on neonatal outcome as respiration and heart rate.

Key facts

Study ID

NCT07343843

Run by

Benha University

People needed

52

Starts

2026-01-17

Expected to finish

2026-07-01

Last updated by the study team

2026-01-21

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Age over 18 years old.
• American Society of Anesthesiologists (ASA) physical status II.
• Scheduled for elective cesarean section (CS) delivery under Central Neuraxial Blockade.
• Provide informed consent and agree to participate in the study.

You may not qualify if…

• Patient's refusal
• Patient known have contraindications for Regional Anesthesia as infection at the site of injection, severe coagulopathy or allergy to local anesthetics.
• Patient with psychiatric disorders.
• Sensory impairment (blindness, deafness).
• Any technical problem preventing proper fitting of the glasses to the patient face.
• Patients with cognitive impairment, epilepsy or with claustrophobia
• Patients with suspected eye infection
• Signs of active labor.
• Pregnancy related-diseases or antepartum hemorrhage.
• Presence of Fetal distress.

Where it is running

• Benha University — Banhā, Benha, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.